Monthly Prescribing Reference

Updated Sublocade Label Includes Rapid Induction, Alternative Injection Sites

Patients not already receiving buprenorphine can receive the first injection of Sublocade following a single dose of transmucosal buprenorphine and a 1 hour observation period to confirm tolerability.
Medscape

Pneumococcal Vaccine Label Adds Injection-Site Risk

A US Food and Drug Administration (FDA) investigation of injection-site necrosis in some people who received the 23-valent pneumococcal vaccine has concluded that the benefits of the vaccine outweigh ...
Healio

Open-label placebo injection demonstrates ‘modest’ benefit in chronic back pain

Please provide your email address to receive an email when new articles are posted on . Open label placebo yielded approximately 1 month of improvement in chronic ...
Monthly Prescribing Reference

FDA: Label Update for Fluorouracil Injection Regarding DPD Deficiency

Fluorouracil is not recommended for use in patients known to have certain homozygous or compound heterozygous DPYD variants that result in complete DPD deficiency. The Food and Drug Administration ...
Nasdaq

Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

Rapid initiation Protocol: Healthcare providers can now initiate treatment with SUBLOCADE after a single dose of transmucosal buprenorphine and a one-hour observation period to confirm ...
Hosted on MSN

Bobbi Althoff Details Botox Side Effects

Podcaster Bobbi Althoff used TikTok to describe side effects from a recent Botox treatment for jaw pain, reviving debate over off-label injections for temporomandibular issues. The video, posted this ...